KCT0004567
Recruiting
未知
prospective cohort study to evaluate the effect of regional nodal irradiation omission on the regional recurrence rate after neoadjuvant chemotherapy followed by breast conserving surgery and sentinal lymph node biopsy in clinical T1-3 with lymph node metastasis in axillary level I and ypN0 breast cancer patient
ational Cancer Center0 sites844 target enrollmentTBD
ConditionsNeoplasms
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Neoplasms
- Sponsor
- ational Cancer Center
- Enrollment
- 844
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Ages eligible for study: between 20\-70 years old
- •2\. Patient must have had pathologic confirmation of invasive breast cancer
- •3\. The patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of
- •4\. Patient must have clinically T1\-3 (before neo\-adjuvant therapy)
- •5\. Patient must have axillary level I nodal involvement at presentation (before neo\-adjuvant therapy) based on either a positive fine needle aspirate (FNA) or positive in positron emission tomography (PET) scan
- •6\. Patients with metastatic lymph node at axilla level I only
- •7\. Patient who have undergone breast conserving surgery
- •8\. Patient who have undergone either sentinel lymph node biopsy or axillary lymph node sampling
- •9\. Patients with pathologic staging of ypN0, ypN0(i\+) or ypN0(mol\+) are eligible (Note: postneo\-adjuvant therapy is designated with a yp prefix.)
- •10\. Patients must have had estrogen receptor (ER), progesterone receptor (PR), HER2, and Ki\-67 index testing performed on the primary breast tumor before neo\-adjuvant therapy
Exclusion Criteria
- •1\. T4 tumors including inflammatory breast cancer
- •2\. Definitive clinical or radiologic evidence of metastatic disease
- •3\. Patients with metastatic lymph node at axilla level II\-III, internal mammary and supraclavicular area by imaging
- •4\. Patient must have not completed a minimum of 50% of standard neo\-adjuvant chemotherapy
- •5\. Patients who showed progression during neo\-adjuvant chemotherapy
- •6\. Patient who have undergone mastectomy
- •7\. Patient who have undergone axillary lymph node dissection
- •8\. Bilateral breast cancer patients
- •9\. Male breast cancer patients
- •10\. Prior breast or thoracic radiation therapy (RT) for any condition
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A pilot study to assess the impact of obstructive sleep apnea (OSA) and treatment with continuous positive airway pressure (CPAP) therapy on maternal blood pressure and placental blood flow in high risk obstetric patientsObstructive sleep apneaMaternal hypertensionRespiratory - Sleep apnoeaReproductive Health and Childbirth - Antenatal careCardiovascular - HypertensionACTRN12618001963213Flinders Medical Centre70
Completed
Not Applicable
The role of exercise in treatment of women with Polycystic Ovary Syndrome (PCOS): mechanisms of actioPolycystic ovary syndromeNutritional, Metabolic, EndocrineOvarian dysfunctionISRCTN84763265Southern Health (Australia)30
Completed
Not Applicable
Telehealth in the home: Testing technology to enhance support and service provision to those either living with or caring for someone with a terminal illness in the communityThe use of telehealth in the palliative care home based community programCancer - Any cancerRespiratory - Chronic obstructive pulmonary diseaseNeurological - Neurodegenerative diseasesACTRN12613000733774Flinders University43
Completed
Not Applicable
The prospective cohort study of the evaluation of Endoscopic Ultrasound-guided Fine Needle Aspiration for pancreatic solid tumorpancreatic solid tumorJPRN-UMIN000005980Clinical application of the new technology for endoscopic diagnosis and researches on the improvement of the diagnostic accuracy230
Completed
Not Applicable
Prospective cohort study to evaluate the effectiveness, safety and long prognosis of endoscopic submucosal dissection for colorectal tumorcolorectal tumorJPRN-UMIN000010155Japan Gastroenterological Endoscopy Society537